Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 20, 2021

Unraveling the substrates of cognitive impairment in multiple sclerosis: A multiparametric structural and functional magnetic resonance imaging study

  • Memory (Cognition)
    /
  • MS Research Study and Reports
    /
 Lorenzo Conti 1, Paolo Preziosa 1 2, Alessandro Meani 1, Elisabetta Pagani 1, Paola Valsasina 1, Olga Marchesi 1, Carmen Vizzino 1, Maria A Rocca 1 2 3, Massimo Filippi 1 2 3 4 5 PMID: 34255918   DOI: 10.1111/ene.15023 PubMed Abstract Background: Cognitive impairment frequently affects…
Memory (Cognition)

October 20, 2021

Evaluate the efficacy and safety of alemtuzumab in CARE-MS II patients over 10 years

  • MS Drug Therapies
    /
Knowing what MS can do to people and seeing these results who wouldn’t want to be treated with, or at…
MS Drug Therapies

October 19, 2021

Study Explores Link Between MS and Bowel Dysfunction

  • Multiple Sclerosis (MS) Symptoms
    /
  The authors of a recent study reviewed the Neurogenic Bowel Dysfunction scores of 1,100 participants across nine multiple sclerosis…
Multiple Sclerosis (MS) Symptoms

October 19, 2021

Majority of People With MS Report Communication Changes

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  A new study investigates the impact of communication changes in the lives of people with multiple sclerosis (MS). The…
Multiple Sclerosis

October 9, 2021

Migraine significantly worsens sleep quality, architecture

  • MIGRAINE
    /
 September 28, 2021 Individuals with migraine had much poorer subjective sleep quality and altered sleep architecture vs. healthy individuals, according…
MIGRAINE

October 8, 2021

1 Year of Ocrevus Not Linked to Higher Risk of Brain Infection PML

  • Multiple Sclerosis
    /
  • Ocrevus
    /
 By Steve Bryson PhD on Oct 07, 2021 One year of Ocrevus (ocrelizumab) treatment does not increase the risk for a rare…
Multiple Sclerosis

October 8, 2021

Depression worsens vascular, mortality outcomes in MS

  • Mental Health
    /
  • MS Specialty Pharmacy
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Source: Adobe Stock  September 13, 2021 Depression appeared to increase risk for incident vascular disease and mortality among individuals with…
Mental Health

October 8, 2021

Newer MS diagnostic criteria show ‘prognostic improvement’

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
 September 27, 2021 Researchers observed a continuous decrease in the time to MS diagnosis and treatment initiation across diagnostic criteria…
MS Research Study and Reports

October 8, 2021

Rituximab, ocrelizumab pose risks in patients with MS and COVID-19

  • #COVID-19
    /
  • Multiple Sclerosis
    /
October 07, 2021 Rituximab and ocrelizumab appeared to increase risk for adverse outcomes among patients with MS and COVID-19, according…
#COVID-19

October 7, 2021

Research News: Hospital Visits for People With MS Rise as Temperatures Increase, Study Finds

  • MS Research Study and Reports
    /
 Medically reviewed by Evelyn O. Berman, M.D. Article written by Torrey Kim October 05, 2021 In a recent retrospective study, researchers analyzed…
MS Research Study and Reports

Categories

Latest Blog Posts